Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 27.06 M26.91 M40.11 M38.55 M 132.62 M Research & development ———— — Operating income -842 K-3.5 M-1.91 M9.34 M 3.1 M Non-Operating Income, Total 443 K-315 K-1.16 M383 K -652 K Interest expense, net of interest capitalized 423 K324 K896 K1.92 M 3.56 M Non-Operating Income, excl. Interest Expenses -423 K-324 K-896 K-1.92 M -3.56 M Unusual income/expense 443 K-315 K-1.16 M383 K -652 K Pretax income -399 K-3.81 M-3.07 M9.73 M 2.45 M Equity in earnings ———— — Taxes 311 K-1.3 M-631 K2.36 M 740 K Non-controlling/minority interest -8 000-49 K-23 K134 K 54 K After tax other income/expense ———— — Net income before discontinued operations -702 K-2.46 M-2.42 M7.23 M 1.65 M Discontinued operations ———— — Net income -702 K-2.46 M-2.42 M7.23 M 1.65 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -702 K-2.46 M-2.42 M7.23 M 1.65 M Basic earnings per share (Basic EPS) -0.04-0.13-0.130.39 0.09 Diluted earnings per share (Diluted EPS) -0.04-0.13-0.130.39 0.09 Average basic shares outstanding 19.34 M19.12 M19.04 M19.3 M — Diluted shares outstanding 19.34 M19.12 M19.04 M19.34 M — EBITDA 9.01 M6.34 M9.27 M15.93 M 40.55 M EBIT -842 K-3.5 M-1.91 M2.84 M -3.4 M Cost of revenue 166.8 M163.5 M194.42 M243.35 M 768.07 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) 9.85 M9.83 M11.17 M13.09 M 43.95 M